Skip to main content
Oncternal Therapeutics, Inc. (ONCT)
Dec 3, 2024 - ONCT trading suspended
0.527
-0.167 (-24.12%)
Inactive · Last trade price on Dec 2, 2024

Oncternal Therapeutics Revenue

Oncternal Therapeutics had revenue of $494.00K in the quarter ending September 30, 2024, with 175.98% growth. This brings the company's revenue in the last twelve months to $2.16M, up 227.92% year-over-year. In the year 2023, Oncternal Therapeutics had annual revenue of $785.00K, down -47.32%.

Revenue (ttm)
$2.16M
Revenue Growth
+227.92%
P/S Ratio
0.72
Revenue / Employee
$72,033
Employees
30
Market Cap
1.56M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023785.00K-705.00K-47.32%
Dec 31, 20221.49M-2.83M-65.47%
Dec 31, 20214.32M940.00K27.85%
Dec 31, 20203.38M950.00K39.18%
Dec 31, 20192.43M-96.00K-3.81%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

ONCT News

More News